Cell Marker Staining
Cell Marker Staining - Related Videos
03:12
May-Grunwald Giemsa Staining: A Method to Stain Bone Marrow Cells
0 Views •
2023
This video describes the technique of staining bone marrow cells using May- Grünwald Giemsa Staining. In the protocol, we will stain the murine myeloid leukemia cells, C149 cells, to analyze the morphology and differential counting.
05:57
Peroxisome Staining in Mammalian Cells Using Peroxisome-Specific Probes
0 Views •
2025
PeroxiSPY probes are used to detect peroxisomes in mammalian cells. Here we demonstrate how to use the probes to stain peroxisomes in live and fixed cells.
03:24
BrdU Immunofluorescence Staining: A Technique to Identify Cells in Different Phases of Cell Cycle
0 Views •
2023
This video describes the protocol for BrdU immunofluorescence staining. The technique allows the identification of cells in different phases of cell cycle. Addition of DNA dyes and antibody labeling allows the detailed analysis of the fate of the S phase cells at later times.
02:52
Giemsa Staining for Colony Formation Assay: An In Vitro Staining Procedure to Assess Proliferative Capability of Mesenchymal Stem Cells
0 Views •
2025
In this video, we demonstrate the Giemsa staining procedure to assess the proliferative potential of mesenchymal stem cells to form viable colonies. Giemsa stain is a neutral stain primarily composed of azure and eosin dyes, which carry selective affinity for cellular components depending on their charge.
02:57
Bacterial Cell Staining and Preparation for Immunological Studies
0 Views •
2025
This video demonstrates the staining and preparation of bacterial cells for immunological studies using red fluorescent dye. The stained bacteria are diluted and resuspended in a growth medium to achieve the desired bacterial concentration for host cell infection, representing the multiplicity of infection.
FAQs
Fluorescent, enzymatic, and chromogenic labels convert probe binding into signals that researchers can detect and measure. The signal appears when an antibody or another binding probe recognizes its cellular target, allowing microscopy or flow cytometry to reveal whether selected markers are present. Label choice therefore determines how the detected binding becomes experimentally observable.
A single marker may not adequately distinguish related cell populations or functional states. Combining several markers creates a profile that can separate immune cell populations and help assess activation or differentiation. In immunology studies, these profiles provide a more informative view of how cellular composition and state change during inflammation, infection, or treatment.
Microscopy and flow cytometry provide different ways to examine marker-associated signals. Microscopy supports visualizing stained cells, whereas flow cytometry enables measurement-based analysis of labeled cell populations. Both approaches can use the resulting signals to characterize immune responses, but the selected platform affects how researchers observe and evaluate the stained cells.
Interpretation depends on which markers were selected, how they distinguish the cell populations of interest, and whether the observed signal corresponds to the intended cellular target. Researchers can examine marker patterns to assess activation, differentiation, or population changes. These results become more informative when interpreted in relation to infection, inflammation, or treatment conditions.
In infection and inflammation research, marker profiles help track changes in immune cell populations and activation states. Researchers can compare stained samples to investigate immune responses and pathogen-host interactions, then examine how those patterns shift during disease processes or treatment. The approach links cellular measurements with changes occurring in the host response.
Treatment studies can use marker patterns to determine whether immune cell populations, activation states, or differentiation profiles change after intervention. Signals measured by microscopy or flow cytometry provide experimental outcomes for comparing cellular responses across conditions. This supports evaluation of therapeutic effects and can help connect treatment exposure with altered immune activity.